Piramal Critical Care announces US launch of Chlorpromazine Hydrochloride for Injection
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
This certification will open new markets for the Kwality Pharma
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
This project is supported by the Irish Government through IDA Ireland
Subscribe To Our Newsletter & Stay Updated